Literature DB >> 26894178

Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients.

Raj Kumar Badam1, Jyotsna Suram2, Dara Balaji Gandhi Babu3, Shefali Waghray4, Rahul Marshal1, Sharath Chandra Bontha5, Reddy Lavanya4, Sudheer Kanth6.   

Abstract

INTRODUCTION: Thyroid carcinoma represents less than 1% of all cancers. The first line of treatment for thyroid cancer is partial/total thyroidectomy. High-dose Iodine(131) therapy using Iodine radioisotopes is commonly used in patients with well differentiated thyroid carcinoma after total thyroidectomy. In this process, the non-thyroidal tissues, such as, salivary gland, stomach and breast tissues also take up radioactive iodine. Salivary gland scintigraphy is widely accepted as a sensitive and valid method for evaluation of salivary gland dysfunction after Radioactive Iodine(131) Therapy (RIT). AIM: To assess and compare the salivary flow rates, relative uptake and ejection fractions in parotid and submandibular glands just before and one month after Iodine(131) therapy.
MATERIALS AND METHODS: The study was conducted on 24 patients diagnosed with well differentiated thyroid carcinoma who underwent partial/total thyroidectomy and were due for radioactive iodine therapy. These patients were divided into two groups based on the lesion based dosimetry (Group A: 60-100Gy; Group B: 100-150Gy). Salivary gland assessment was done by salivary gland scintigraphy before and after RIT. STATISTICAL ANALYSIS: The data collected was tabulated and statistically analysed using SPSS software version16 using paired t-test and individual sample t-test.
RESULTS: A statistically significant difference in the uptake percent and ejection fraction percent in the parotid and submandibular glands before RIT and one month after RIT was observed in the study.
CONCLUSION: We inferred from the study that there was an overall decrease in uptake percent and ejection fraction percent one month post RIT in both parotid and submandibular glands. Also, a statistically significant difference was noted in the uptake and ejection fraction percent between Group A and Group B concluding the fact that the damage is dose related.

Entities:  

Keywords:  Radioisotopes; Radionuclide imaging; Xerostomia

Year:  2016        PMID: 26894178      PMCID: PMC4740706          DOI: 10.7860/JCDR/2016/16091.7121

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Persistent sialadenitis after radioactive iodine therapy: report of two cases.

Authors:  S J Mandel; L Mandel
Journal:  J Oral Maxillofac Surg       Date:  1999-06       Impact factor: 1.895

2.  Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren's syndrome.

Authors:  W Aung; Y Murata; R Ishida; Y Takahashi; N Okada; H Shibuya
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

3.  Hospital discharge of patients with thyroid carcinoma treated with 131I.

Authors:  Carlos D Venencia; Alejandro G Germanier; Silvia R Bustos; Andrea A Giovannini; Eduardo P Wyse
Journal:  J Nucl Med       Date:  2002-01       Impact factor: 10.057

Review 4.  Salivary gland dysfunction and swallowing disorders.

Authors:  R N Stuchell; I D Mandel
Journal:  Otolaryngol Clin North Am       Date:  1988-11       Impact factor: 3.346

5.  Radioisotope scanning of the salivary glands. A preliminary report.

Authors:  G A Gates; W P Work
Journal:  Laryngoscope       Date:  1967-05       Impact factor: 3.325

6.  Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.

Authors:  S P Cholewinski; K S Yoo; P S Klieger; R E O'Mara
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

7.  Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.

Authors:  Shin Young Jeong; Hae Won Kim; Sang-Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

8.  Evaluation of Salivary Gland Dysfunction Using Salivary Gland Scintigraphy in Sjögren's Syndrome Patients and in Thyroid Cancer Patients after Radioactive Iodine Therapy.

Authors:  Ji Yeon Kang; Su Jin Jang; Won Woo Lee; Sung June Jang; Yun Jong Lee; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-07-08

9.  [Clinical picture and possible causes of functional disorders of the parotid gland in radioiodine therapy of differentiated thyroid cancer].

Authors:  M Deeg; H Maier; H Bihl; D Adler
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1988-07

10.  Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates.

Authors:  W G Kohn; J A Ship; J C Atkinson; L L Patton; P C Fox
Journal:  J Oral Pathol Med       Date:  1992-02       Impact factor: 4.253

View more
  5 in total

1.  A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to 131I therapy in Patients with Differentiated Thyroid Carcinoma.

Authors:  Yasuhiro Maruoka; Shingo Baba; Takuro Isoda; Yoshiyuki Kitamura; Koichiro Abe; Masayuki Sasaki; Hiroshi Honda
Journal:  J Clin Diagn Res       Date:  2017-08-01

2.  Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.

Authors:  Arun Upadhyaya; Zhaowei Meng; Peng Wang; Guizhi Zhang; Qiang Jia; Jian Tan; Xue Li; Tianpeng Hu; Na Liu; Pingping Zhou; Sen Wang; Xiaoxia Liu; Huiying Wang; Chunmei Zhang; Fengxiao Zhao; Ziyu Yan
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management.

Authors:  Sonia Mahajan; Ravinder K Grewal; Kent P Friedman; Heiko Schöder; Neeta Pandit-Taskar
Journal:  Transl Oncol       Date:  2022-05-03       Impact factor: 4.803

4.  Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis.

Authors:  Xiaolan Lv; Liang Yin; Weiming Wu; Ning Li; Ruyi Zhang; Xue Li; Qiang Jia; Jian Tan; Peng Wang; Xiangqian Zheng; Xianghui He; Chao Huang; Dihua Li; Yan Wang; Zhaowei Meng
Journal:  J Healthc Eng       Date:  2022-04-14       Impact factor: 3.822

5.  Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with 177Lu-PSMA and Combined 225Ac- and 177Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.

Authors:  Thomas Langbein; Harshad R Kulkarni; Christiane Schuchardt; Dirk Mueller; Gerd Fabian Volk; Richard P Baum
Journal:  Diagnostics (Basel)       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.